SAM #75N98026Q00482

NIH NCI In Vitro Testing Services for Small-Molecule Drug Candidates

The National Institutes of Health (NIH), through its Office of Logistics and Acquisition Operations (OLAO) and the National Cancer Institute (NCI), is seeking specialized in vitro testing services for small-molecule drug candidates to support anticancer drug discovery and development. - Government Buyer: - Department of Health and Human Services (HHS) - National Institutes of Health (NIH) - National Cancer Institute (NCI), Division of Cancer Treatment and Diagnosis (DCTD), Developmental Therapeutics Program (DTP) - OEMs and Vendors: - Cyprotex US LLC is identified as the sole known source capable of meeting the technical and logistical requirements for these services - Products/Services Requested: - In vitro testing services for small-molecule drug candidates - Includes laboratory assays using cells, tissues, and enzymes to predict compound behavior and support anticancer drug development - No specific part numbers or quantities provided - Unique or Notable Requirements: - Services must support the Developmental Therapeutics Program's anticancer drug discovery efforts - Cyprotex US LLC is noted as the only vendor able to meet the technical and logistical needs - Place of Performance: - NIH facilities in Bethesda, Maryland - Contracting office located at 6011 Executive Blvd., Suite 503L, Bethesda, MD 20892

Description

Attachment: Notice of Intent

View original listing